DENVER--(BUSINESS WIRE)--VieCure today announced a new collaboration with Labcorp to provide clinicians greater access to precision oncology decision support. This strategic collaboration will support ...

In Nigeria, SYNLAB Nigeria’s expansive medical test bouquet reflects how integrated testing is redefining the journey toward ...

Making is Fueling Strong Growth in Pan-Genomic and Multi-Gene Panel Testing, Supported by Expanding NGS Access, Advanced ...

Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of its Research Use Only (RUO) ...

Therapeutic decision making for patients with advanced non–small cell lung cancer (aNSCLC) includes a growing number of options for genomic, biomarker-guided, targeted therapies. We compared ...

TAIPEI, Nov. 28, 2025 /PRNewswire/ -- Precision medicine is entering a new era, driven by breakthroughs in genetic technology and Artificial Intelligence (AI). Multi-Cancer Early Detection (MCED) has ...

Gone are the days when oncologists reacted to a cancer diagnosis by using the few drugs we had and hoping for the best. We have evolved from being reactive to proactive, primarily due to advances in ...

LONDON--(BUSINESS WIRE)-- Smiths Detection, a global leader in threat detection and security screening technologies, and a business of Smiths Group plc, today announces the launch of the SDX 6040 ...

Huepar, a global leader in high-precision laser levels and measuring tools, recently concluded its strategic milestone event, the "Huepar 2025 China Tour." While titled a tour, this initiative served ...